Nov 3, 8:11 AM ET
Waters Corporation reported third-quarter 2026 total revenue of $1.767 billion and adjusted EPS of $4.10, driven by 9% organic revenue growth. Supported by strong operational momentum and integration progress, the company raised its full-year 2026 reported revenue and adjusted EPS guidance, while also announcing the acquisition of MOBILion Systems, Inc.
- Total reported revenue for the third quarter ended October 3, 2026, reached $1.767 billion, with GAAP EPS of $0.82 and adjusted EPS of $4.10.
- Organic revenue grew 9% as reported and 10% in constant currency during the third quarter.
- The company raised its full-year 2026 reported revenue guidance by $43 million at the midpoint to a range of $6.479 billion to $6.497 billion.
- Full-year 2026 adjusted EPS guidance was updated to a range of $14.60 to $14.70.
Read the filing on SEC.gov ↗
Aug 21, 9:20 AM ET
Waters disclosed that Robert L. Carpio III resigned as Senior Vice President of its Analytical Sciences Division to pursue other opportunities, relinquishing his duties on August 20, 2026. Tina Wu, currently SVP of Materials Sciences and President, China, will take over the Analytical Sciences role, a leadership change in a business unit.
- Robert L. Carpio III notified Waters on August 17, 2026 of his resignation as SVP, Waters Analytical Sciences Division.
- Carpio relinquished his duties effective August 20, 2026.
- Tina Wu, SVP, Waters Materials Sciences Division and President, China, will assume the Analytical Sciences SVP role.
- Wu joined Waters in June 2026 after more than 20 years at DuPont, most recently as Global Vice President and President of DuPont Mobility & Materials since 2021.
Read the filing on SEC.gov ↗
Aug 4, 6:10 AM ET
Waters reported second-quarter 2026 results on August 4, 2026, with reported revenue of $1.645 billion, up from $771 million a year earlier. The acquired Biosciences and Diagnostic Solutions businesses contributed $817 million of that revenue. The company posted a GAAP net loss of $136 million, or $1.39 per diluted share, reflecting acquisition-related purchase accounting charges, while adjusted EPS rose 3% to $3.05 and Waters raised all components of its full-year 2026 guidance.
- Organic revenue of $828 million grew 7% as reported and 9% in constant currency.
- GAAP diluted loss of $1.39 per share, compared with diluted EPS of $2.47 in the second quarter of 2025.
- Adjusted EPS of $3.05, compared with $2.95 a year earlier.
- Full-year 2026 adjusted EPS guidance raised to $14.45 to $14.65; total reported revenue expected at $6.415 billion to $6.476 billion.
Read the filing on SEC.gov ↗
May 5, 6:10 AM ET
Waters reported first-quarter 2026 revenue of $1.267 billion, $56 million above the high end of its guidance range, and adjusted EPS of $2.70, up 20% from $2.25 a year earlier. The company raised its full-year 2026 adjusted EPS guidance to $14.40 to $14.60 and its organic constant currency revenue growth guidance to 6.5% to 8.0%. GAAP results were a loss of $0.87 per diluted share, reflecting acquisition-related purchase accounting charges from the Becton, Dickinson biosciences and diagnostics business acquired February 9, 2026.
- Revenue was $1.267 billion versus $662 million a year earlier, including $520 million from the acquired Biosciences and Diagnostic Solutions businesses.
- Organic revenue grew 13% as reported and 11% in constant currency, to $747 million.
- GAAP diluted loss of $0.87 per share compared with diluted EPS of $2.03 a year earlier; purchased intangibles amortization was $152 million.
- Second-quarter 2026 adjusted EPS guidance is $2.95 to $3.05; full-year 2026 reported revenue is expected at $6.405 billion to $6.455 billion.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.